# | Filing Date | Period End Date | Type | Report Link |
---|---|---|---|---|
No Data found |
# | Date | Analyst Firm | Upside/Downside | Price Target Change | Rating Change | Current Rating |
---|
CSBR: 59% | Champions Oncology shares are trading higher after the company reported better-than-expected Q1 financial results. ...
Craig-Hallum analyst Matt Hewitt upgrades Champions Oncology (NASDAQ:CSBR) from Hold to Buy and maintains the price target f...
Champions Oncology (NASDAQ:CSBR) reported quarterly earnings of $0.11 per share which beat the analyst consensus estimate of $(...
Champions Oncology (NASDAQ:CSBR) reported quarterly earnings of $0.01 per share which beat the analyst consensus estimate of $(...